Efficacy and safety of caspofungin in solid organ transplant recipients.
暂无分享,去创建一个
S. Vuocolo | N. Kartsonis | C. Sable | A. Williams-Diaz | A. Ngai | S. Bradshaw | J. Petrović | A. Taylor
[1] R. Betts,et al. Caspofungin for the treatment of less common forms of invasive candidiasis. , 2007, The Journal of antimicrobial chemotherapy.
[2] A. Glasmacher,et al. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis , 2006, Cancer.
[3] Nina Singh,et al. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? , 2006, Current opinion in infectious diseases.
[4] P. Marik. Fungal infections in solid organ transplantation , 2006, Expert opinion on pharmacotherapy.
[5] D. Stablein,et al. Post‐Transplant Infections Now Exceed Acute Rejection as Cause for Hospitalization: A Report of the NAPRTCS 1 , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] J. Sobel,et al. Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Nina Singh,et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1 , 2003, Transplantation.
[8] J. Perfect,et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. , 2002, The New England journal of medicine.
[9] J. Smietana,et al. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. , 2002, The American journal of medicine.
[10] E. Gotuzzo,et al. Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases , 2002, Antimicrobial Agents and Chemotherapy.
[11] E. Gotuzzo,et al. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] N. Singh. Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management. , 2000, The Journal of antimicrobial chemotherapy.
[13] Nina Singh,et al. Invasive aspergillosis in transplant recipients. , 1999, Medicine.
[14] C. Payá,et al. Fungal infections in solid-organ transplantation. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] J. Ortiz,et al. Fungal infections in solid organ transplant patients. , 2003, Surgical infections.
[16] T. Starzl,et al. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. , 1996, Annals of surgery.